UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Janssen says its multiple myeloma drug combo halves death risk
by Marian Chu
2017-12-13 15:22
FDA approves treatment for eosinophilic granulomatosis with polyangiitis
by Lee Han-soo
2017-12-13 14:35
Celgene, Bluebird Bio’s CAR-T therapy proves 94% response in P1 study
by Marian Chu
2017-12-13 14:30
AstraZeneca to test Imfinzi on lung cancer patients
by Lee Hye-seon
2017-12-13 14:20
Wholesalers sweat over drug companies’ forceful sales
by So Jae-hyeon
2017-12-13 11:33
라인
Misdiagnosis of Segawa syndrome sparks public debate
by Lee Han-soo
2017-12-13 11:26
Hanmi leads erectile dysfunction drug sales
by Marian Chu
2017-12-12 17:49
What is healthcare like up north?
by Marian Chu
2017-12-12 17:25
‘Surge of gene-therapy providing hospitals to benefit Invossa’
by Nam Doo-hyun
2017-12-12 15:59
Bio-industry output sees steady growth
by Lee Han-soo
2017-12-12 15:52
라인
Drugmakers lead job growth in manufacturing sector
by So Jae-hyeon
2017-12-12 15:12
President Moon promises proper reimbursements for physicians
by Choi Gwang-seok
2017-12-12 14:26
Korea approves Olumiant pills for treatment of rheumatoid arthritis
by Lee Hye-seon
2017-12-12 11:50
Huons wins patent for oral medication of clarithromycin
by Lee Han-soo
2017-12-12 11:41
PCL shares rise despite regulator’s warning
by Nam Doo-hyun
2017-12-12 11:02
라인
JW Pharma unveils trial result for target anticancer treatment
by Lee Han-soo
2017-12-11 16:55
Pfizer pays most to doctors for overseas academic events
by So Jae-hyeon
2017-12-11 16:28
Oscotec shares rebound on launch of US clinical trial
by Nam Doo-hyun
2017-12-11 15:50
Korea becomes 10th nation to join international medical device group
by Marian Chu
2017-12-11 15:25
ToolGen’s shares jump on gene therapy market expectations
by Nam Doo-hyun
2017-12-11 15:16
-
이전
251
252
253
254
255
256
257
258
259
260
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top